MedTrace Logo

Zero-fluoroscopy Approach Versus Fluoroscopic Approach for the Ablation of Paroxysmal Supraventricular Tachycardia

NCT03042078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3060

Last updated 2023-11-24

No results posted yet for this study

Summary

This study is aimed to compare the feasibility, safety and efficacy of a zero-fluoroscopic approach using Ensite NavX with conventional fluoroscopic approach using Ensite NavX plus fluoroscopy for the ablation of paroxysmal supraventricular tachycardia.

Conditions

  • Paroxysmal Supraventricular Tachycardia

Interventions

DEVICE

Zero-fluoroscopic ablation

Catheter ablation will be performed under the guidance of Ensite NavX and without the use of fluoroscopy.

DEVICE

Conventional fluoroscopic ablation

Catheter ablation will be performed under the guidance of Ensite NavX plus fluoroscopy.

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences, Fuwai Hospital

    collaborator OTHER

  • First Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • Xiangyang Central Hospital

    collaborator OTHER

  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER

  • Guangdong Provincial People's Hospital

    collaborator OTHER

  • Morristown Memorial Hospital

    collaborator OTHER

  • Beijing Anzhen Hospital

    collaborator OTHER

  • Ningbo No. 1 Hospital

    collaborator OTHER

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Yan Wang, PhD · Tongji Hospital Wuhan, Hubei China

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2018-02-28
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03042078 on ClinicalTrials.gov